Okava Pharmaceuticals

To develop life-saving medicines for dogs and cats by repurposing proven human drugs and optimizing them for pets using advanced drug delivery technologies.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded October 2015
  • Employees 5
  • Incorporation Type C-corp
  • Website okavapharma.com

Company Summary

We needlessly euthanize household pets because effective treatment options are lacking. For example, tens of thousands of diabetic cats are annually euthanized in the US alone.

Okava’s products will not only prevent needless euthanasia, they’re targeting $1B+ market opportunities.

By repurposing proven human technologies, Okava has a low-risk, fast (<$5M) model for developing life-saving treatments.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free